Sanara MedTech Inc. — Director's Dealing 2022

Mar 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2022-01-01

Reporting Person: Morrison Christopher A. (President - Telehealth Svcs.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-01	Common Stock	A	7135	—	Acquired	28032	Direct

Footnotes

F1: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long Term Incentive Plan. The shares vest in four equal installments, with one-fourth of the shares vesting on April 1, 2022, and the remainder vesting in three equal installments on July 1, 2022, October 1, 2022, and January 1, 2023, respectively.